Arcus Biosciences, Inc. (RCUS) Q3 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Arcus Biosciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.347 -- 00:00:06.573 Good afternoon. Thank you for attending today's Arcus Biosciences third quarter 2024 00:00:06.573 -- 00:00:11.017 earnings call. My name is Tamia and I will be your moderator for today's call. 00:00:11.017 -- 00:00:14.521 All lines will be muted during the presentation portion of the call with an opportunity 00:00:14.521 -- 00:00:18.706 for questions and answers at the end. If you would like to ask a question, please press 00:00:18.706 -- 00:00:22.650 star one on your telephone keypad. I would now like to pass the conference over to your 00:00:22.650 -- 00:00:25.733 host, Tia Eves, Vice President of Investor Relations. 00:00:25.733 -- 00:00:27.993 You may proceed. 00:00:28.786 -- 00:00:33.313 Hello everyone, and thank you for joining us on today's conference call to discuss our 00:00:33.313 -- 00:00:38.721 third quarter, 2024 financial results and pipeline updates, including our upcoming presentation 00:00:38.721 -- 00:00:43.668 of our 10 data at 50. I'd like to remind you that on this call management will make forward 00:00:43.668 -- 00:00:48.255 looking statements, including statements about our cash runway and our expected clinical 00:00:48.255 -- 00:00:52.850 development milestones and timelines all statements other than historical facts. 00:00:52.850 -- 00:00:57.236 reflect the current beliefs and expectations of management, and involve risks and uncertainties 00:00:57.236 -- 00:01:00.780 that may cause our actual results to differ from those expressed. 00:01:00.780 -- 00:01:04.706 Those risks and uncertainties are described in our most recent quarterly report on Form 00:01:04.706 -- 00:01:09.972 10-Q that has been filed with the SEC. Today, you'll hear from our CEO, 00:01:09.972 -- 00:01:15.440 Terry Rosen, CMO, Dimitri Naugh...